mRNA Vaccines: Not Ready For Prime Time. The Risks and Realities

I’m in the charge group. I know I’m not built like most men though.
If an intruder broke into my house and approached my son’s bedroom, I wouldn’t hide under the sheets to see how things played out before reacting either.

There’s a middle ground between charging into your death and hiding under the sheets you know

If you are open to change, try reading the book “Strategy”, by BH Liddell Hart. It explains why the Wehrmact kicked ass against the West (six weeks to effectively knock out France), and then did so well against Russia for 2 years, until they ran out of men.

Did they charge straight into the Maginot Line?

No. They went around. “Cowards!”, you might say.

Turns out that strategy is a thing. But only for those flexible enought to learn new concepts. I read this book when I was a kid. I never forgot its lessons.

1 Like

I’m in no way open to changing my mind that the intentional slaughter of our children should have stopped Jan 21st.
Maybe you could consider my dog on the porch story.
My Dad and I were at my cousins house when I was a kid. Their dog went over to his full dog bowl, sniffed it and walked away looking unhappy.
My Dad said to my Uncle Jerry “I don’t think he likes it”
“In 2 or 3 days he will” he responded.

That’s most of us here. We haven’t had anything good to eat in 5 years and are starving for anything good.
Trump pointing out obvious things like getting men out of women’s sports even makes me cheer for him. We are all that malnourished for integrity and sanity.
People have become weak mentally from the hunger, even the folks here like yourself that are probably much more educated and knowledgeable about many things I know nothing about.
Everyone has a plan until they get hit.
Some collapse. I get up swinging no matter how big they are or what could happen to me. That doesn’t always work out in your own best interests like you correctly point out. Everyone has to be their own Man.

2 Likes

Does that ground have a comfortable chair on it to sit in while children are murdered? Is it a lazy boy or something garbage from one of those discount shops? There is a difference in comfort

Heh. I guess that’s a “no, not interested in new concepts.”
No problem. I’ll move on.

There’s some people here that really want to believe in your position on this :+1:t2: I think you will look back on this later and feel different. If not, the killing will be stopped and the plan to save us will be evident to all.
I’ll be thrilled to be wrong about it

1 Like

Resources Regarding LNP Distribution Courtesy DeepSeek.

Here are key references discussing the biodistribution and dispersion of lipid nanoparticles (LNPs) in the body, focusing on both therapeutic applications and mechanistic studies:


1. mRNA Vaccine and LNP Biodistribution

  • Title: “SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness”
    Authors: Corbett, K.S. et al.
    Journal: Nature (2020)
    DOI: 10.1038/s41586-020-2622-0
    Summary: Preclinical data on Moderna’s mRNA-1273 vaccine, showing LNP distribution in mice after intramuscular injection, with primary uptake in the liver and immune cells.

  • Title: “BNT162b2 Vaccine Biodistribution in Rats” (Pfizer-BioNTech COVID-19 Vaccine Study)
    Journal: European Medicines Agency (EMA) Assessment Report (2021)
    Link: EMA Report
    Summary: Radiolabeled LNP data in rats showing transient distribution to the liver, spleen, adrenal glands, and ovaries, with eventual clearance.


2. Role of Ionizable Lipids and Formulation

  • Title: “Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics”
    Authors: Hou, X. et al.
    Journal: Pharmaceutics (2021)
    DOI: 10.3390/pharmaceutics13070945
    Summary: Reviews how ionizable lipids and PEGylation influence LNP biodistribution, including liver-targeted vs. systemic dispersion.

  • Title: “Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms”
    Authors: Akinc, A. et al.
    Journal: Molecular Therapy (2010)
    DOI: 10.1038/mt.2010.85
    Summary: Early work on ionizable LNPs showing liver tropism and factors affecting systemic distribution.


3. siRNA-LNP Therapeutics (e.g., Patisiran)

  • Title: “Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis”
    Authors: Adams, D. et al.
    Journal: New England Journal of Medicine (2018)
    DOI: 10.1056/NEJMoa1716153
    Summary: Clinical study of the first FDA-approved LNP-siRNA drug, highlighting hepatic uptake and systemic effects.

4. Imaging and Mechanistic Studies

  • Title: “In Vivo Fate Analysis of Lipid Nanoparticles”
    Authors: Sato, Y. et al.
    Journal: Journal of Controlled Release (2020)
    DOI: 10.1016/j.jconrel.2020.10.014
    Summary: Uses fluorescent labeling to track LNPs in mice, showing accumulation in the liver, spleen, and lungs.

  • Title: “The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs”
    Authors: Kulkarni, J.A. et al.
    Journal: Nature Nanotechnology (2021)
    DOI: 10.1038/s41565-021-00898-0
    Summary: Discusses how LNP design impacts biodistribution, including avoidance of renal clearance and RES uptake.


5. Reviews on LNP Biodistribution

  • Title: “mRNA-LNP Formulations: Advances in Tissue-Specific Delivery”
    Authors: Schoenmaker, L. et al.
    Journal: International Journal of Pharmaceutics (2021)
    DOI: 10.1016/j.ijpharm.2021.120445
    Summary: Analyzes how LNP composition and size influence dispersion to tissues beyond the liver.

  • Title: “Lipid Nanoparticles for mRNA Delivery”
    Authors: Buschmann, M.D. et al.
    Journal: Nature Reviews Materials (2021)
    DOI: 10.1038/s41578-021-00358-0
    Summary: Comprehensive review of LNP design principles and their impact on systemic vs. localized delivery.


Key Takeaways:

  • LNPs predominantly accumulate in the liver due to apolipoprotein adsorption and uptake by hepatocytes.
  • PEGylation and surface modifications can prolong circulation, enabling broader dispersion (e.g., spleen, lungs).
  • Intramuscular vs. intravenous administration significantly alters distribution patterns.
  • Preclinical models show transient off-target distribution (e.g., ovaries, adrenal glands), but clinical relevance remains debated.

I have heard of places that will do MRI and other screenings on demand for a price. I seem to recall the cost being less than I would have expected. Perhaps you can find an option like that in conjunction with a practitioner who has the knowledge base you need.

Here you go George. This is from a Japanese release (accidental?) from the FDA filing showing a trititated LNP distribution (scintillation study) in rats.

And here’s a review article with actual mRNA products involved (testing for the mRNA distribution mostly). You want table 2.

2 Likes

Listening to that video was like some sort of re-exposure therapy or something. I found myself feeling a lot of emotions while I took a trip back through several years of gaslighting and mind F’ery perpetrated by governments and institutions I had either trusted to some extent or thought were net beneficial to humanity in their overall functions. Perhaps the previous degree of naivety is the cause of my discomfort.

My career, credentials and professional integrity were never publicly assaulted and yet I have a lot of emotions connected to these topics. I was impressed to see you all stay composed while processing it all yet again, while knowing what has been done to all of you by the media, social media and “fact checkers” et al.

Thanks Chris. Of course you know how much I appreciate you and your time. It looks like the target dose of 50 micrograms mRNA is within the range of human target dose of 30 pfiser and 100 moderna. I am hoping the relatively high dose / animal weight means there would be less distributed to soft tissue in humans.

The thought of plasmid contaminant integrating into fast growing cancer cells … yikes!

you could try FLCC is now the IMA s… they were the forefront and treat vax injury and I can’t imagine the other doctors here not sharing info on treatments real time with McCollough and Kory " but hey thats your interview to ask em" so potentially you could probably get a similar level of care is they are involved in vax treatment program…

below is the link to the provider search… note even thought they are nationwide , they are not a large practice you may have to drop in zip codes for bigger cities near you to find one within driving distance… but that said…its doable to find a knowledgeable practitioner somewhat near you

https://imahealth.org/providers/